Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prodromal Alzheimer Disease”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Testing effectiveness (Phase 2)Ended earlyNCT04592341
What this trial is testing

Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 192
Not applicableLooking for participantsNCT07239310
What this trial is testing

Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease(AD)
Deepsonbio 138
Not applicableLooking for participantsNCT05629871
What this trial is testing

Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline?

Who this might be right for
Neuropathology
University Hospital, Montpellier 132
Not applicableStudy completedNCT05309577
What this trial is testing

Self-Care for Dementia Caregivers

Who this might be right for
AgingMental DisorderEating, Healthy+6 more
University of Pittsburgh 21
Early research (Phase 1)Study completedNCT01978548
What this trial is testing

Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 45
Not applicableUnknownNCT04137926
What this trial is testing

Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT06182085
What this trial is testing

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease, Early Onset
PRInnovation GmbH 304
Not applicableEnded earlyNCT04846426
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 67
Early research (Phase 1)Ended earlyNCT01677572
What this trial is testing

Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 197
Testing effectiveness (Phase 2)WithdrawnNCT05986721
What this trial is testing

Clinical Trial of AGB101 for Mild Cognitive Impairment

Who this might be right for
Mild Cognitive ImpairmentProdromal Alzheimer's Disease
AgeneBio
Not applicableStudy completedNCT04733989
What this trial is testing

A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease, Early OnsetMild Cognitive Impairment+3 more
GAP Innovations, PBC 1,002
Not applicableUnknownNCT04851496
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639050
What this trial is testing

Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 241
Not applicableEnded earlyNCT04951284
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 42
Early research (Phase 1)Study completedNCT04566003
What this trial is testing

Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease (AD)
Genentech, Inc. 40
Large-scale testing (Phase 3)Ended earlyNCT03114657
What this trial is testing

Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 806
Large-scale testing (Phase 3)Ended earlyNCT02760602
What this trial is testing

Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 26
Testing effectiveness (Phase 2)Looking for participantsNCT04804241
What this trial is testing

Senicapoc in Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
University of California, Davis 55
Testing effectiveness (Phase 2)Study completedNCT04867616
What this trial is testing

Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
UCB Biopharma SRL 466
Testing effectiveness (Phase 2)Looking for participantsNCT07477431
What this trial is testing

Levetiracetam for Persons at Risk for Alzheimer's Disease

Who this might be right for
Hippocampal HyperactivationProdromal Alzheimer Disease
Sunnybrook Health Sciences Centre 40
Load More Results